Literature DB >> 26107157

Expanding Therapy With Long-Acting Antipsychotic Medication in Patients With Schizophrenia.

William T Carpenter1, Robert W Buchanan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26107157     DOI： 10.1001/jamapsychiatry.2015.0485

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN： 2168-622X            Impact factor:   21.596


× No keyword cloud information.
  7 in total

1.  New EMA report on paliperidone 3-month injections: taking clinical and policy decisions without an adequate evidence base.

Authors:  G Ostuzzi; D Papola; C Gastaldon; C Barbui
Journal:  Epidemiol Psychiatr Sci       Date:  2016-12-22       Impact factor: 6.892

2.  Adherence to antipsychotic medication among homeless adults in Vancouver, Canada: a 15-year retrospective cohort study.

Authors:  Stefanie N Rezansoff; A Moniruzzaman; S Fazel; R Procyshyn; J M Somers
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-06-23       Impact factor: 4.328

Review 3.  Barriers to the Use of Long-Acting Injectable Antipsychotics in the Management of Schizophrenia.

Authors:  Eduard Parellada; Miquel Bioque
Journal:  CNS Drugs       Date:  2016-08       Impact factor: 5.749

4.  Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image study.

Authors:  Miquel Bioque; Eduard Parellada; Clemente García-Rizo; Sílvia Amoretti; Adriana Fortea; Giovanni Oriolo; Pol Palau; Ester Boix-Quintana; Gemma Safont; Miquel Bernardo
Journal:  Eur Psychiatry       Date:  2020-07-16       Impact factor: 5.361

5.  Effectiveness of More Personalized, Case-Managed, and Multicomponent Treatment for Patients with Severe Schizophrenia Compared to the Standard Treatment: A Ten-Year Follow-Up.

Authors:  Juan J Fernández-Miranda; Silvia Díaz-Fernández; Francisco López-Muñoz
Journal:  J Pers Med       Date:  2022-07-04

6.  Effect of long-acting injectable antipsychotics on hospitalizations and global functioning in schizophrenia: a naturalistic mirror-image study.

Authors:  Cristiana Montemagni; Elisa Del Favero; Elena Cocuzza; Flavio Vischia; Paola Rocca
Journal:  Ther Adv Psychopharmacol       Date:  2022-10-08

7.  Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy.

Authors:  Giovanni Ostuzzi; Maria Angela Mazzi; Samira Terlizzi; Federico Bertolini; Andrea Aguglia; Francesco Bartoli; Paola Bortolaso; Camilla Callegari; Mariarita Caroleo; Giuseppe Carrà; Mariangela Corbo; Armando D'Agostino; Chiara Gastaldon; Claudio Lucii; Fabio Magliocco; Giovanni Martinotti; Michela Nosé; Edoardo Giuseppe Ostinelli; Davide Papola; Marco Piero Piccinelli; Alberto Piccoli; Marianna Purgato; Tommaso Tabacchi; Giulia Turrini; Mirella Ruggeri; Corrado Barbui
Journal:  PLoS One       Date:  2018-08-02       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.